{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:18:30Z","timestamp":1790914710427,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Observational studies report some association between circulating bilirubin levels and osteoporosis, but it is unknown if this association is causal or confounded. In this two-sample Mendelian randomization (MR) study, we included a large genome-wide association study (GWAS) associated with total bilirubin levels among 317,639 people, a large meta-analysis to identify genetic variants associated with bone mineral density (BMD) estimated by heel quantitative ultrasound (eBMD) among 426,824 individuals and fracture among 1.2 million individuals. The results revealed that circulating bilirubin levels had no causal influence on eBMD (beta-estimate: 0.004, 95% confidence interval [CI]:\u00a0-0.019 to 0.028, SE:0.012, P-value=0.705) or the risk of fracture (beta-estimate: -0.009, 95% CI: -0.035 to 0.017, SE:0.013, P-value=0.488), which were both confirmed by multiple sensitivity analyses. Our results confirm that circulating bilirubin levels have no causal role in eBMD or the incidence of fracture, indicating that circulating bilirubin levels is unlikely to be a causal risk factor for osteoporosis or fracture.<\/jats:p>","DOI":"10.3389\/fendo.2021.719920","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T06:27:41Z","timestamp":1629959261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Systematic Influence of Circulating Bilirubin Levels on Osteoporosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinqiu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxue","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0302-x","article-title":"An Atlas of Genetic Influences on Osteoporosis in Humans and Mice","volume":"51","author":"Morris","year":"2019","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01041-6","article-title":"State of the Art in Osteoporosis Risk Assessment and Treatment","volume":"42","author":"Liu","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical Femur Fracture Risk Versus Fragility Fracture Prevention With Bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz162","article-title":"Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis","volume":"105","author":"Leder","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0339-7","article-title":"A Broader Strategy for Osteoporosis Interventions, Nature Reviews","volume":"16","author":"Reid","year":"2020","journal-title":"Endocrinology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis Treatment: Recent Developments and Ongoing Challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet (Lond Engl)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone Disease in Primary Biliary Cirrhosis: Independent Indicators and Rate of Progression","volume":"35","author":"Menon","year":"2001","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of Cholestasis and Advanced Histological Stage But Not Menopausal Status Are the Major Risk Factors for Osteoporosis in Primary Biliary Cirrhosis","volume":"42","author":"Gua\u00f1abens","year":"2005","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/jhep.2002.36357","article-title":"Bone Metabolism in Advanced Cholestatic Liver Disease: Analysis by Bone Histomorphometry","volume":"36","author":"Guichelaar","year":"2002","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24605","article-title":"Effects of Bilirubin and Sera From Jaundiced Patients on Osteoblasts: Contribution to the Development of Osteoporosis in Liver Diseases","volume":"54","author":"Ruiz-Gasp\u00e0","year":"2011","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00220.2005","article-title":"Products of Heme Oxygenase and Their Potential Therapeutic Applications","volume":"290","author":"Kirkby","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2020.1783290","article-title":"Bilirubin Binding Affects the Structure and Function of Alpha-2-Macroglobulin","volume":"41","author":"Ali","year":"2020","journal-title":"J Immunoassay Immunochem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200201000-00008","article-title":"Increased Rate of Bone Loss at the Femoral Neck in Patients With Chronic Liver Disease","volume":"14","author":"Ormarsd\u00f3ttir","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.2.282","article-title":"Osteoporosis in Primary Biliary Cirrhosis Revisited","volume":"49","author":"Newton","year":"2001","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-013-0452-y","article-title":"Effects of Total Bilirubin on the Prevalence of Osteoporosis in Postmenopausal Women Without Potential Liver Disease","volume":"31","author":"Bian","year":"2013","journal-title":"J Bone Mineral Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3228","article-title":"Genetics of Osteoporosis From Genome-Wide Association Studies: Advances and Challenges, Nature Reviews","volume":"13","author":"Richards","year":"2012","journal-title":"Genetics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2019.04.005","article-title":"The Genetic Architecture of Osteoporosis and Fracture Risk","volume":"126","author":"Trajanoska","year":"2019","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41574-019-0282-7","article-title":"A Road Map for Understanding Molecular and Genetic Determinants of Osteoporosis","volume":"16","author":"Yang","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6835","article-title":"Combining Information on Multiple Instrumental Variables in Mendelian Randomization: Comparison of Allele Score and Summarized Data Methods","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2434","article-title":"Mendelian Randomization Analysis to Examine for a Causal Effect of Urate on Bone Mineral Density","volume":"30","author":"Dalbeth","year":"2015","journal-title":"J Bone Mineral Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00886-5","article-title":"Depression and Osteoporosis: A Mendelian Randomization Study","author":"He","year":"2021","journal-title":"Calcified Tissue Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7499.1076","article-title":"What Can Mendelian Randomisation Tell Us About Modifiable Behavioural and Environmental Exposures","volume":"330","author":"Davey Smith","year":"2005","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian Randomisation Studies: A Guide, Glossary, and Checklist for Clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators","volume":"178","author":"Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using Published Data in Mendelian Randomization: A Blueprint for Efficient Identification of Causal Risk Factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00757-z","article-title":"Genetics of 35 Blood and Urine Biomarkers in the UK Biobank","volume":"53","author":"Sinnott-Armstrong","year":"2021","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting Findings From Mendelian Randomization Using the MR-Egger Method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: An R Package for Performing Mendelian Randomization Analyses Using Summarized Data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base Platform Supports Systematic Causal Inference Across the Human Phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred From Mendelian Randomization Between Complex Traits and Diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852","article-title":"A Model to Predict Poor Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00589-0","article-title":"Circulating Total Bilirubin and Risk of Non-Alcoholic Fatty Liver Disease in the PREVEND Study: Observational Findings and a Mendelian Randomization Study","volume":"35","author":"Kunutsor","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2018.05.013","article-title":"Direct Bilirubin Is Associated With Low-Density Lipoprotein Subfractions and Particle Size in Overweight and Centrally Obese Women","volume":"28","author":"Kwon","year":"2018","journal-title":"Nutrition Metabol Cardiovasc Dis: NMCD"},{"key":"B36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2474-8-124","article-title":"Oxidative Stress as a Risk Factor for Osteoporosis in Elderly Mexicans as Characterized by Antioxidant Enzymes","volume":"8","author":"S\u00e1nchez-Rodr\u00edguez","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7067984","DOI":"10.1155\/2016\/7067984","article-title":"Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses","volume":"2016","author":"Zhou","year":"2016","journal-title":"Dis Markers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2013.07.007","article-title":"Observational Research\u2013Opportunities and Limitations","volume":"27","author":"Boyko","year":"2013","journal-title":"J\u00a0Diabetes Its Complicat"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(03)00100-4","article-title":"Natural History of Primary Biliary Cirrhosis","volume":"7","author":"Par\u00e9s","year":"2003","journal-title":"Clinics Liver Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian Randomization\u2019: Can Genetic Epidemiology Contribute to Understanding Environmental Determinants of Disease","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.719920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T11:25:58Z","timestamp":1630754758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.719920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":40,"alternative-id":["10.3389\/fendo.2021.719920"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.719920","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"article-number":"719920"}}